about
Dissociation of Down syndrome and Alzheimer's disease effects with imaging.Con: are we ready to translate Alzheimer's disease-modifying therapies to people with down syndrome?Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanismsCerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer's disease.Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation.Dyrk1 inhibition improves Alzheimer's disease-like pathology.Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.Down syndrome, beta-amyloid and neuroimaging.Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis.Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndromeSynaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease modelsCorrection of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
P2860
Q33816076-79BB4695-CAEB-4CA5-B192-2815BB7D1973Q34630597-95612DDB-7935-4AFF-BAEE-359FD126A06FQ36712099-5B407BAE-C884-4CC4-A196-2967548879C8Q36767734-B644D6CE-3D72-4326-BD55-34F7DA6E7708Q37279515-DECA0568-D099-4231-8A55-3CDAEB83F5C0Q37299293-21637445-6634-425C-A3CB-D5D53C6C69E3Q39433562-608871D7-E10B-4CCE-85BE-44D7D407FFAAQ41228349-B7BB4796-8B46-42CF-BD53-A41C92898192Q41628814-491DD954-1137-4BEE-BB4B-BFB7401E97F6Q47253602-53623A57-49DC-48FE-97F0-CED96ADB9B86Q47953822-9DFEBC19-30A9-42B5-ACFC-1611772D44C3Q48102481-320BBBB9-3712-4778-9713-6ECAF90D99BDQ52340254-6D1F834B-EB36-4FB4-B9D4-D0C108DDED05Q55443889-14C6E99C-7C0C-4656-8114-28E4A5596B8FQ58609012-D5D34C97-28BA-4121-8409-30218C90095EQ58762401-33491355-ABFA-4F44-A042-637C06EF8BEAQ59127645-A170F0BE-F380-4417-A38E-81AF828DAFDD
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Alzheimer's Disease in Down Syndrome.
@ast
Alzheimer's Disease in Down Syndrome.
@en
type
label
Alzheimer's Disease in Down Syndrome.
@ast
Alzheimer's Disease in Down Syndrome.
@en
prefLabel
Alzheimer's Disease in Down Syndrome.
@ast
Alzheimer's Disease in Down Syndrome.
@en
P2093
P2860
P1476
Alzheimer's Disease in Down Syndrome.
@en
P2093
Brian T Gold
David Powell
Elizabeth Head
Frederick A Schmitt
P2860
P304
P577
2012-12-01T00:00:00Z